Financials data is unavailable for this security.
View more
Year on year Allarity Therapeutics Inc had revenues remain flat at 0.00, though the company grew net income from a loss of 16.06m to a smaller loss of 11.90m.
Gross margin | -- |
---|---|
Net profit margin | -- |
Operating margin | -- |
Return on assets | -52.54% |
---|---|
Return on equity | -190.32% |
Return on investment | -110.73% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Allarity Therapeutics Inc fell by 1.86m. Cash Flow from Financing totalled 11.00m or -- of revenues. In addition the company used 12.75m for operations while cash from investing was breakeven.
Cash flow per share | -100.64 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 16.98 |
---|---|
Tangible book value per share | 8.80 |
More ▼
Balance sheet in USDView more
Current ratio | 2.01 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0668 |
---|---|
Total debt/total capital | 0.0626 |
More ▼